A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases

The GM2-gangliosidoses are neurological diseases causing premature death, thus developing effective treatment protocols is urgent. GM2-gangliosidoses result from deficiency of a lysosomal enzyme β-hexosaminidase (Hex) and subsequent accumulation of GM2 gangliosides. Genetic changes in HEXA, encoding...

Descripción completa

Detalles Bibliográficos
Autores principales: Ou, Li, Przybilla, Michael J, Tăbăran, Alexandru-Flaviu, Overn, Paula, O’Sullivan, M. Gerard, Jiang, Xuntian, Sidhu, Rohini, Kell, Pamela J., Ory, Daniel S., Whitley, Chester B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260097/
https://www.ncbi.nlm.nih.gov/pubmed/31896760
http://dx.doi.org/10.1038/s41434-019-0120-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7260097/
https://www.ncbi.nlm.nih.gov/pubmed/31896760
http://dx.doi.org/10.1038/s41434-019-0120-5

Ejemplares similares